AIP
TXG icon

Ameritas Investment Partners’s 10x Genomics TXG Stock Holding History

Ameritas Investment Partners’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$415K Buy
10,821
+1,860
+21% +$48.7K 0.01% 974
2026
Q1 		$190K Hold
8,961
– – 0.01% 1291
2025
Q4 		$146K Hold
8,961
– – ﹤0.01% 1461
2025
Q3 		$105K Sell
8,961
-1,821
-17% -$23.7K ﹤0.01% 1657
2025
Q2 		$125K Buy
+10,782
New +$98.3K ﹤0.01% 1602

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameritas Investment Partners's TXG Position: Q2 2026 in Review

Ameritas Investment Partners increased its 10x Genomics (TXG) stake by 21% in Q2 2026, buying an estimated $48.7K and bringing the position to 10,821 shares worth $415K. The position accounts for 0.01% of the portfolio, ranked #974.

Ameritas Investment Partners first reported a position in TXG in Q2 2025 and has held it in 5 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Ameritas Investment Partners held 10,821 shares of 10x Genomics worth $415K as of Q2 2026.
  • Ameritas Investment Partners bought 1,860 10x Genomics shares in Q2 2026, an estimated $48.7K.
  • 10x Genomics made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #974 holding.
  • Ameritas Investment Partners first reported a position in 10x Genomics in Q2 2025 and has held it in 5 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.